Sarepta Therapeutics to Announce Fourth Quarter & Full-Year 2016 Financial Results & Recent Corporate Developments on Februar...
February 15 2017 - 8:31AM
Business Wire
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a developer of
innovative RNA-targeted therapeutics, will report fourth quarter
and full-year 2016 financial results after the NASDAQ Global
Market closes on Tuesday, February 28, 2017. Subsequently,
at 4:30 p.m., Eastern Time, Edward Kaye, M.D., Sarepta’s
chief executive officer, Sandy Mahatme, Sarepta’s chief
financial officer, and Bo Cumbo, Sarepta’s senior vice president of
global commercial development will host a conference call to
discuss fourth quarter and full-year financial results and to
provide a corporate update.
The conference call may be accessed by dialing (574) 990-1451
for domestic callers and (844) 534-7313 for international callers.
The passcode for the call is 73840094. Please specify to the
operator that you would like to join the "Sarepta Fourth Quarter
and Full-Year 2016 Earnings Call." The conference call will be
webcast live under the investor relations section of Sarepta's
website at www.sarepta.com and will be archived there
following the call for 90 days. Please connect to Sarepta's website
several minutes prior to the start of the broadcast to ensure
adequate time for any software download that may be necessary.
About SareptaSarepta Therapeutics is a commercial-stage
biopharmaceutical company focused on the discovery and development
of unique RNA-targeted therapeutics for the treatment of rare
neuromuscular diseases. The Company is primarily focused on rapidly
advancing the development of its potentially disease-modifying DMD
drug candidates. For more information, please visit us at
www.sarepta.com.
Internet Posting of InformationWe routinely post
information that may be important to investors in the 'For
Investors' section of our web site at www.sarepta.com. We
encourage investors and potential investors to consult our website
regularly for important information about us.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170215005620/en/
Media and Investors:Sarepta Therapeutics, Inc.Ian Estepan,
617-274-4052iestepan@sarepta.comorW2O GroupBrian Reid,
212-257-6725breid@w2ogroup.com
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Apr 2024 to May 2024
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From May 2023 to May 2024